Nulibry is approved by the U.S. Food and Drug Administration (USFDA) to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A, an ultra-rare, life-threatening paediatric genetic disorder
Agreement builds on previous Novartis success using emerging technologies to develop first-in-class gene therapies for neurological disorders
The DCGI has already approved Covovax for restricted use in emergency situations in adults on December 28th 2021
JEEN’s portfolio includes a diverse range of specialized active ingredients, botanical extracts, and complexes serving functional applications for skin and hair care
New results build on previously reported significant recurrence-free survival (rfs) benefit seen in these patients
Alongside brand refresh, the leading clinical trial technology company announces eConsent and eCOA offerings to better support the patient clinical trial journey
Expanding the Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers
NATCO and Teva are launching these strengths of lenalidomide pursuant to a license of patents owned by Celgene
First advanced hybrid closed-loop insulin pump system in India features automatic insulin delivery, automatic correction boluses, and bluetooth connectivity
Taisho Pharmaceutical will bring its experience and expertise in the research and development of therapeutic products to the collaboration.
Subscribe To Our Newsletter & Stay Updated
